Abstract
Abstract: Needleless and needle protector intravenous systems have taken the place of 80% of needles used in IV therapy. Although these new systems are marketed as safe, many have not been widely tested and are not fail-safe. Each of the needleless IV systems and needle protector systems has limitations and potential benefit when applied in the appropriate circumstances. The benefits and limitations of these devices in today's healthcare market are discussed.